These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10901376

  • 1. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
    Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Abra RM, Stewart JS.
    Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.
    Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS.
    Clin Cancer Res; 2001 Feb; 7(2):243-54. PubMed ID: 11234875
    [Abstract] [Full Text] [Related]

  • 6. Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection.
    Syrigos KN, Vile RG, Peters AM, Harrington KJ.
    Acta Oncol; 2003 Feb; 42(2):147-53. PubMed ID: 12801133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preclinical characterisation of 111In-DTPA-trastuzumab.
    Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG.
    Br J Pharmacol; 2004 Sep; 143(1):99-106. PubMed ID: 15289297
    [Abstract] [Full Text] [Related]

  • 10. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S.
    Clin Cancer Res; 2003 Dec 15; 9(17):6551-9. PubMed ID: 14695160
    [Abstract] [Full Text] [Related]

  • 18. Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.
    Harrington KJ, Rowlinson-Busza G, Syrigos KN, Vile RG, Uster PS, Peters AM, Stewart JS.
    Clin Cancer Res; 2000 Dec 15; 6(12):4939-49. PubMed ID: 11156255
    [Abstract] [Full Text] [Related]

  • 19. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
    Ward MC, Roberts KR, Westwood JH, Coombes RC, McCready VR.
    J Nucl Med; 1986 Nov 15; 27(11):1746-50. PubMed ID: 3464701
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.